Clinical Trial Update: An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial investigates intravenous immunoglobulin (IVIG) as a treatment for spinocerebellar ataxias; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxias

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of South Florida | Conditions: Spinocerebellar Ataxias | Phase 1 | Status: UNKNOWN